-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd4-final-protocol.pdf
October 01, 2022 - outcome, PTSD diagnostic change, PTSD clinically meaningful
change
o Other outcomes - anxiety, anger, depression … with health
and functional outcomes including PTSD symptoms and diagnosis, substance use, anxiety,
depression … cannot be standalone PTSD
interventions (i.e., interventions targeting
PTSD and a comorbidity such as depression … Census categories)
m. % Treatment-naïve
n. % with depression
o. % with substance use disorder
p. … Between-group effect sizes for all reported depression outcomes
m.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-protocol-2021_0.pdf
January 01, 2021 - outcome, PTSD diagnostic change, PTSD clinically
meaningful change
o Other outcomes - anxiety, anger, depression … with
health and functional outcomes including PTSD symptoms and diagnosis, substance use, anxiety,
depression … cannot be standalone
PTSD interventions (i.e., interventions
targeting PTSD and a comorbidity such as
depression … Census categories)
m. % Treatment-naïve
n. % with depression
o. % with substance use disorder
p. … Between-group effect sizes for all reported depression outcomes
m.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/traumatic-brain-injury-rehabilitation_research-protocol.pdf
October 25, 2010 - planning, and spatial
orientation.
8
Sustained affective/behavioral impairments include anxiety, depression … Studies not
excluded by both investigators during triage will undergo screening. … Differences in screening decisions will be resolved by a third investigator. … status of each study and the reason for exclusion in
the project library of citations relevant for screening … with the AND operator to create a precise set of
literature inclusive of all concepts for initial screening
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_research-protocol.pdf
January 30, 2014 - abuse and neglect, early separation from their parents
including adoption, and maternal anxiety and depression … increased risk.23
Risk attributable to factors such as maternal smoking, substance use, and anxiety and
depression … Screening and extraction forms
We will develop forms for screening (abstract and full-text review) and … the reported
variables from included studies and organize into meaningful groups (e.g., maternal
depression … We will use DistillerSR (Evidence Partners, Ottawa, Canada) for screening
references.
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1406.pdf
January 01, 2020 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments, screening … for emergency treatment of
known or suspected opioid overdose, characterized by respiratory system depression … , central
nervous system depression, or both. … , central nervous system depression, or both.27,33
Diffusion: In a press release, the manufacturer
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
March 17, 2020 - patients.1
We recognize that many PGHD applications require manual entry of data, particularly
those for depression … For full-text
screening, each article will be screened by two people, with disagreements resolved by … INCLUDE:
Systematic reviews
will only be used for
the purpose of
screening their
included studies … Systematic reviews were
used only for screening of
their reference lists.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/impact-healthcare-algorithms-racial-ethnic-disparities-March-3.pdf
July 01, 2023 - Healthcare costs of utilization
Intensive care needs
Kidney function
Lung function
Lung cancer screening … Opioid misuse
Organ donation
Postpartum depression
Stroke risk
Warfarin dosing
14 … function
GLI spirometry equation for lung function
Novel risk prediction algorithm for postpartum depression … representation
4 ASCVD for cardiovascular disease risk
Novel risk prediction algorithm for postpartum depression … algorithm for opioid misuse
Statistical techniques 2 Novel risk prediction algorithm for postpartum depression
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-centered-medical-home_research-protocol.pdf
February 23, 2012 - Guideline-concordant care processes, or scores on broadly accepted
performance measures (e.g., rate of depression … screening) such as those
endorsed by the National Quality Forum or National Committee on Quality … Articles included by either
reviewer will undergo full-text screening. … At the full-text screening stage, two
independent reviewers must agree on a final inclusion/exclusion … Educational and organizational interventions to
improve the management of depression in primary care
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-genetic.ppt
June 01, 2012 - Screening for hereditary hemochromatosis: a systematic review for the U.S. … Are preliminary screening questions employed?
6. … If it is part of a series of screening tests, are all tests performed in all instances
(parallel … Estimated analytic validity of HFE C282Y mutation testing in population screening: the potential value … Screening for hereditary hemochromatosis: a systematic review for the U.S.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-genetic.ppt
June 01, 2012 - Screening for hereditary hemochromatosis: a systematic review for the U.S. … Are preliminary screening questions employed?
6. … If it is part of a series of screening tests, are all tests performed in all instances
(parallel … Estimated analytic validity of HFE C282Y mutation testing in population screening: the potential value … Screening for hereditary hemochromatosis: a systematic review for the U.S.
-
effectivehealthcare.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
January 01, 2011 - reducing
breast cancer mortality, but these countries do not
routinely have concurrent mammogram screening … Comparative Effectiveness of Second-
Generation Antidepressants in the
Pharmacologic Treatment of Adult
Depression … Screening for Breast Cancer. … applicability of evidence
Population Available trials included few patients with PSA detected by screening … Scandinavian Prostate Cancer Screening
Group Study No. 4.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-applicability_methods.pdf
January 01, 2011 - reducing
breast cancer mortality, but these countries do not
routinely have concurrent mammogram screening … Comparative Effectiveness of Second-
Generation Antidepressants in the
Pharmacologic Treatment of Adult
Depression … Screening for Breast Cancer. … applicability of evidence
Population Available trials included few patients with PSA detected by screening … Scandinavian Prostate Cancer Screening
Group Study No. 4.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-5-protocol-update-2023.pdf
January 01, 2023 - outcome, PTSD diagnostic change, PTSD clinically meaningful
change
o Other outcomes - anxiety, anger, depression … with health
and functional outcomes including PTSD symptoms and diagnosis, substance use, anxiety,
depression … cannot be standalone PTSD
interventions (i.e., interventions targeting
PTSD and a comorbidity such as depression … Census categories)
15. % Treatment-naive
16. % with comorbidities: depression, substance use disorder … Between-group effect sizes for depression, anxiety, sleep, anger, quality of life, function, and
substance
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol.pdf
January 31, 2023 - current disruptive behaviors/conduct problems was 7.4%
(compared with 7.1% for anxiety and 3.2% for depression … Prevalence and treatment of depression,
anxiety, and conduct problems in us children. … training" or "aggression questionnaire" or "aggression
replacement training" or "antisocial process screening
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
March 05, 2015 - Do the authors really mean to
say “depression comparisons”? … I would think many of the studies
actually assessed depressive symptoms, not depression by DSM
criteria … The reviewer is correct—the term “depression” can
be interpreted to mean clinical depression. … To avoid
confusion, the term “depressive symptoms” has
replaced “depression” when appropriate. … written out and description added:
“A total of 7019 records could be excluded in the first
round of screening
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gaps-pain-management.pdf
January 01, 2023 - on opioid use and adverse events in
addition to patient-reported outcomes (e.g.,
quality of life, depression … opioids versus nonopioid
medications in improvement in pain, function,
mental health status, sleep, or depression … • Studies on the effects of risk mitigation
strategies (use of naloxone, urine drug
screening, prescription … Ketamine may cause more
dizziness or overall side effects, while
opioids may cause more respiratory
depression … Ketamine may cause more dizziness or overall side effects, while opioids may cause more respiratory depression
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline_executive.pdf
March 01, 2017 - Certain medical conditions are associated with an
increased risk of developing MCI and CATD, including
depression … interventions of interest were absent from the literature
altogether, including interventions aimed at depression … placebo and
angiotensin receptor blockers (ARBs) versus placebo have no benefit on brief cognitive screening … or CATD incidence.
• Low-strength evidence shows no benefit for low-dose aspirin on brief cognitive screening … • We found no relevant studies for depression treatments, smoking cessation, or community-level interventions
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_executive.pdf
March 01, 2017 - Certain medical conditions are associated with an
increased risk of developing MCI and CATD, including
depression … interventions of interest were absent from the literature
altogether, including interventions aimed at depression … placebo and
angiotensin receptor blockers (ARBs) versus placebo have no benefit on brief cognitive screening … or CATD incidence.
• Low-strength evidence shows no benefit for low-dose aspirin on brief cognitive screening … • We found no relevant studies for depression treatments, smoking cessation, or community-level interventions
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-research-report-integrating-health-system-data.pdf
April 01, 2020 - Permanente used their own internal data to help operationalize the implementation of guidelines
on screening … /monitoring intervals based on one of three risk groups as opposed to
universally applied screening/ … For example, depression management and suicide prevention
have been top priorities for the VA in recent … Screening for Asymptomatic Carotid Artery
Stenosis: A Systematic Review and Meta-
Analysis for the U.S … Screening for Abnormal Glucose and Type 2
Diabetes Mellitus: A Systematic Review to
Update the 2008
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/mmm-draft-protocol-amendment.pdf
February 02, 2022 - Duplicate citations will be removed prior to screening. … Two independent investigators will
perform full-text screening to determine if inclusion criteria are … Throughout the screening process, team members
will meet regularly to discuss training materials and … Severe maternal morbidity: screening and review. Am J Obstet Gynecol.
2016;215(3):B17–B22.
3. … For
example, social stigma related to
substance use and its impact on
depression would be interpersonal